期刊文献+

广西非小细胞肺癌组织中EGFR基因表达的研究 被引量:1

Expression of EGFR in Tissues of Non-small Cell Lung Cancer in Guangxi
下载PDF
导出
摘要 目的探讨非小细胞肺癌(NSCLC)组织中表皮生长因子受体(EGFR)的表达情况及其与临床病理、民族的关系。方法采用荧光定量PCR检测76例NSCLC患者(肺癌组)和23例癌旁组织及8例非癌肺组织(非癌组织组)EGFR的表达。结果 EGFR mRNA在肺癌组中表达量高于癌旁组织组,癌旁组织组表达量高于非癌组织组(P<0.05)。EGFR表达与肿瘤的病理类型、性别、年龄、民族、吸烟指数无明显相关性(P>0.05),Ⅲ期、Ⅳ期表达量高于Ⅰ期、Ⅱ期,有淋巴结转移者高于无淋巴结转移者(P<0.05)。结论广西NSCLC患者癌组织中EGFR呈高表达,并且其表达与肿瘤临床分期及有否淋巴结转移有关。 Objective To investigate the expression of epidermal growth factor receptor(EGFR)in non-small cell lung cancer(NSCLC)tissue and its relation with clinical pathology and nationality.Methods The expressions of EGFR in 76 lung cancer samples,23 adjacent samples and 8 non-lung cancer samples were detect by real-time PCR.Results The expression of EGFR in lung cancer samples was higher than that in adjacent samples,which was higher than that in non-cancer samples(P0.05).The expression of EGFR had no obvious correlation with pathologic type type,gender,age,nationality and smoking index(P0.05).The expression in the stages Ⅲ-Ⅳ was higher than that in the stagesⅠ-Ⅱ,and that with lymphatic metastasis was higher than that without lymph node metastasis(P0.05).Conclusion There is high EGFR expression in cancer tissue of NSCLC patients in Guangxi,which is related with clinical stages of tumor and lymph node metastasis.
出处 《广西医学》 CAS 2011年第4期413-416,共4页 Guangxi Medical Journal
基金 广西科学研究与技术开发计划项目(10124001A-44) 广西研究生创新教育计划项目(2010105981002M181) 广西壮族自治区大型仪器网测试项目
关键词 非小细胞肺癌 表皮生长因子受体 荧光定量PCR 广西 民族 Non-small cell lung cancer Epidermal growth factor receptor Real-time PCR Guangxi Zhuang nationality
  • 相关文献

参考文献9

  • 1Willim SC,Cheri SL,Martin P,et al.Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of EGF receptor[J].Nature,1987,328(9):820-823.
  • 2蒲萍,李光辉,李德志,段玉忠,曹正怀,陈正堂.血清糖类抗原检测在非小细胞肺癌诊断、转归中的意义[J].重庆医学,2009,38(5):552-553. 被引量:3
  • 3Ullrich A,Coussens L,Hayflick JS,et al.Human epidermal growth factor receptor cDNA sequence and aberrant expression of amplified gene in A341 epidennoid carcinoma cells[J].Nature,1984,309(5 967):418-425.
  • 4Mendelsohn J,Baselga J.Status of epidermal growth factor receptor ntagonists in the biology and treatment of cancer[J].J Clin Oncol,2003,21(14):2 787-2 799.
  • 5Jorissen RN,Walker F,Pouliot N,et al.Epidermal growth factor receptor:mechanisms of activation and signallng[J].Exp Cell Res,2003,284(1):31-53.
  • 6Byers LA,Heymach JV.Dual targeting of the vascular endothelial growth factor and epidermal growth factor receptor pathways:rationale and clinical applications for non-small cell lung cancer[J].Clin Lung Cancer,2007,8(suppl 2):79-85.
  • 7Perez-Soler R,Chachoua A,Hammond LA,et al.Determinants of tumor response and survival with erlotinib in patients with non-small cell lung cancer[J].J Clin Oncol,2004,22(16):3 238-3 247.
  • 8Fukuoka M,Wu Y,Thongprasert S,et al.Biomarker analyses from a phase Ⅲ,randomized,open-label,first-line study of gefitinib(G)versus carboplatin/pacl itaxel(C/P)in clinically selected patients(pts)with advanced non-small cell lung cancer(NSCLC)in Asia(IPASS)[J].J Clin Oncol,2009,15(Supp 1):8 006.
  • 9孙光远,赵学维,李兵,徐志飞,何金,刘惠敏.EGFR在女性非小细胞肺癌中的表达及临床意义[J].中国癌症杂志,2007,17(5):380-384. 被引量:10

二级参考文献21

共引文献11

同被引文献13

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部